相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulatory T cells are less sensitive to glucocorticoid hormone induced apoptosis than CD4+T cells
Lilla Prenek et al.
APOPTOSIS (2020)
Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms
Natasha C. Ward et al.
DIABETES (2020)
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
James R. Burke et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
Michelle Rosenzwajg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2
Guillaume Churlaud et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Regulatory T cells in autoimmune disease
Margarita Dominguez-Villar et al.
NATURE IMMUNOLOGY (2018)
Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
Jiatao Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells
Natasha C. Ward et al.
JOURNAL OF IMMUNOLOGY (2018)
Revisiting IL-2: Biology and therapeutic prospects
Abul K. Abbas et al.
SCIENCE IMMUNOLOGY (2018)
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Caroline von Spee-Mayer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Restoring regulation - IL-2 therapy in systemic lupus erythematosus
Jens Y. Humrich et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care
I. N. Bruce et al.
LUPUS (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Michelle Rosenzwajg et al.
JOURNAL OF AUTOIMMUNITY (2015)
T cells in the control of organ-specific autoimmunity
Jeffrey A. Bluestone et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
David Klatzmann et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Engineering of a Novel Anti-CD40L Domain Antibody for Treatment of Autoimmune Diseases
Jenny H. Xie et al.
JOURNAL OF IMMUNOLOGY (2014)
The need to define treatment goals for systemic lupus erythematosus
Kate Franklyn et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Emeline Castela et al.
JAMA DERMATOLOGY (2014)
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
Janice P. Dutcher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
IL-2R Signaling Is Essential for Functional Maturation of Regulatory T Cells during Thymic Development
Guoyan Cheng et al.
JOURNAL OF IMMUNOLOGY (2013)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells
Aixin Yu et al.
IMMUNITY (2009)
Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality
F. Goldblatt et al.
LUPUS (2009)
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction
Qizhi Tang et al.
IMMUNITY (2008)
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages
Machteld M. Tiemessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nonredundant roles for Stat5a/b in directly regulating Foxp3
Zhengju Yao et al.
BLOOD (2007)
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Matthew A. Williams et al.
NATURE (2006)
A function for interleukin 2 in Foxp3-expressing regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Infectious complications in SLE after immunosuppressive therapies
I Kang et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice:: implications for the nonredundant function of IL-2
TR Malek et al.
IMMUNITY (2002)
Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer
PG Fraenkel et al.
JOURNAL OF IMMUNOTHERAPY (2002)
分享论文
